Updated Lecture 4

Fundamentals of Gene Expression and Epigenetics

  • Genomic Equivalence and Cellular Specialization:

    • Every somatic nucleated cell in a multicellular organism possesses an identical complement of genomic DNA sequences.

    • Cellular diversity and functional specialization (e.g., neurons, cardiomyocytes, hepatocytes, adipocytes, enterocytes, and chondrocytes) arise not from genetic differences, but from selective transcriptional regulation.

    • A gene is defined as expressed when it is actively transcribed into messenger RNA (mRNA\text{mRNA}), which is subsequently translated into a functional protein.

    • Pluripotent stem cells within the blastocyst harbor the developmental capacity to differentiate into all embryonic cell lineages through tightly coordinated spatial and temporal programs of gene expression.


Differentiation of pluripotent stem cells into specialized cell types
  • Definition of Epigenetics:

    • The Greek prefix epi- translates to over, outside of, or around.

    • Epigenetics refers to heritable alterations in gene expression and chromatin organization that occur without any alteration to the underlying primary nucleotide sequence of DNA.

    • Epigenetic mechanisms operate as an instructive regulatory layer directly superimposed upon the genetic code.

    • Unlike static genomic mutations, epigenetic modifications are inherently reversible, dynamic, and subject to modulation by environmental stimuli, nutritional factors, and pharmacological agents.

DNA Methylation and CpG Islands

  • Biochemical Characteristics of DNA Methylation:

    • DNA methylation entails the covalent addition of a methyl group (−CH3-\text{CH}_3) to nitrogenous bases of nucleotides, occurring primarily at the carbon-5 position of cytosine to yield 5-methylcytosine5\text{-methylcytosine} (5mC5\text{mC}), and substantially less frequently on adenine residues.

    • The methyl group projects directly into the major groove of the DNA double helix, directly altering the steric and electrostatic landscape of the DNA molecule.


Chemical structure and enzymatic conversion of cytosine to 5-methylcytosine
  • CpG Dinucleotides and Genomic Depletion:

    • Methylation occurs almost exclusively in the sequence context of a cytosine followed immediately by a guanine residue in the 5′→3′5'\rightarrow 3' direction, designated as a 5′-CpG-3′5'\text{-CpG-}3' dinucleotide.

    • The lowercase "p\text{p}' denotes the intervening phosphodiester linkage within the single-strand backbone, distinguishing dinucleotide sequences from a complementary Guanine-Cytosine (G≡C\text{G}\equiv\text{C}) base pair across the double helix.

    • Based on an average genomic G+C\text{G}+\text{C} content of 42%42\%, the mathematically predicted frequency of CpG dinucleotides is approximately 4.4%4.4\%     Expected Frequency=0.21×0.21=0.0441 (4.41%)\text{Expected Frequency} = 0.21 \times 0.21 = 0.0441\, (4.41\%)

    • In reality, CpG dinucleotides are observed at an actual frequency of only ≈1%\approx 1\% across the human genome, representing severe evolutionary CpG suppression caused by spontaneous deamination of 5-methylcytosine5\text{-methylcytosine} into thymine (T\text{T}).


Structure of the 5'-CpG-3' dinucleotide within the double helix
  • CpG Islands in Gene Promoters:

    • CpG Islands are localized genomic clusters (≈300 to 3,000 base pairs\approx 300\text{ to }3{,}000\,\text{base pairs} in length) displaying a significantly elevated density of unmethylated CpG dinucleotides compared to the genome average.

    • CpG islands are predominantly localized within the core promoter and first exon regions of approximately 60 to 70%60\text{ to }70\% of all human genes (such as the promoter and Exon 1 CpG island of the cystic fibrosis transmembrane conductance regulator, CFTR\textit{CFTR}, encompassing coordinates 12634 to 1276712634\text{ to }12767).


UCSC Genome Browser track demonstrating a dense CpG island at the CFTR promoter
  • Mechanisms of Transcriptional Repression via CpG Methylation:

    • Steric Hindrance: Methyl groups protruding into the major groove directly block the physical binding of sequence-specific transcription factors and RNA Polymerase II transcriptional machinery.

    • Effector Protein Recruitment: Methylated CpG dinucleotides recruit Methyl-CpG-Binding Domain proteins (MBDs / methyl-binding proteins). These recruit multi-subunit corepressor complexes containing Histone Deacetylases (HDACs) and chromatin-remodeling enzymes, precipitating local chromatin compaction and stable gene silencing.

    • Reversibility: Active and passive DNA demethylation reactivates silenced genes and corrects aberrant methylation patterns during development or tissue repair.


Transcriptional activation with unmethylated CpG islands versus repression by methylated CpG islands

DNA Methyltransferases: Maintenance vs. De Novo Methylation

  • Maintenance Methylation:

    • Catalyzed primarily by DNA Methyltransferase 1 (DNMT1).

    • Following semi-conservative DNA replication, newly synthesized double-stranded DNA is hemimethylated (methylated on the parental template strand, unmethylated on the nascent daughter strand).

    • DNMT1 exhibits a high stereochemical affinity for hemimethylated CpG sites, specifically methylating the complementary cytosine on the newly synthesized strand.

    • This preserves lineage-specific methylation landscapes across cell divisions, serving as the biological mechanism of somatic epigenetic inheritance.

  • De Novo Methylation:

    • Catalyzed primarily by DNMT3A and DNMT3B (acting in coordination with the non-catalytic accessory factor DNMT3L).

    • Adds novel methyl groups to completely unmethylated double-stranded DNA substrates.

    • Acts during gametogenesis, blastocyst post-implantation, and early embryonic differentiation to establish cell-type-specific epigenetic patterns.


Mechanisms of maintenance methylation following DNA replication versus de novo methylation
  • Tissue-Specific Epigenetic Regulation:

    • Differential promoter methylation governs lineage-specific gene activation.

    • In hepatocyte nuclei, liver-specific metabolic genes maintain unmethylated CpG islands (actively transcribed, "ON"), while renal-specific genes are heavily methylated and silenced ("OFF").

    • Conversely, in renal epithelial cells, kidney-specific functional genes remain unmethylated and active ("ON"), while liver-specific genes are methylated and suppressed ("OFF").

Chromatin Structure and Histone Post-Translational Modifications

  • The Nucleosome Core Particle:

    • The nucleosome represents the fundamental repeating unit of eukaryotic chromatin packaging.

    • It comprises a central histone octamer consisting of two copies each of core histone proteins:     2×(H2A,H2B,H3,H4)2 \times (\text{H2A}, \text{H2B}, \text{H3}, \text{H4})

    • Approximately 146 to 147 base pairs146\text{ to }147\,\text{base pairs} of DNA wound in 1.651.65 left-handed superhelical turns around the octamer core.

    • Linker Histone H1 binds to the exterior of the core particle at the DNA entry and exit sites, sealing the nucleosome and directing higher-order folding into condensed chromatin fibers.


Schematic representation of the nucleosome core octamer wrapped with DNA and stabilized by histone H1
  • Chromatin Conformational States:

    • Euchromatin:

      • Characterized by an open, dispersed "beads-on-a-string" architecture.

      • High accessibility to basal transcription factors, transcriptional coactivators, and RNA Polymerase II.

      • Transcriptionally competent and active.

    • Heterochromatin:

      • Characterized by tightly aggregated, highly condensed chromatin fibers.

      • Excludes transcriptional machinery, producing robust transcriptional silencing.

      • Subdivided into constitutive heterochromatin (permanently silenced regions, including telomeres and pericentromeric satellites) and facultative heterochromatin (regions reversibly packaged and silenced in a developmental or cell-type-specific manner).


Open configuration of euchromatin compared to tightly condensed heterochromatin
  • Histone Acetylation Dynamics:

    • Chemical Reaction: Covalent transfer of an acetyl group (−COCH3-\text{COCH}_3) from acetyl-CoA to the ϵ\epsilon-amino group of positively charged lysine residues located on amino-terminal histone tails.

    • Enzymatic Regulators:

      • Histone Acetyltransferases (HATs): Catalyze lysine acetylation, neutralizing positive charges.

      • Histone Deacetylases (HDACs): Catalyze the hydrolytic cleavage of acetyl groups, restoring the positive charge on lysine side chains.

    • Mechanism of Action:

      • Positively charged lysine residues normally form strong electrostatic bonds with negatively charged phosphate moieties (PO43−\text{PO}_4^{3-}) along the DNA backbone.

      • Neutralization of this positive charge reduces histone-DNA binding affinity, resulting in steric unwrapping and chromatin relaxation into euchromatin.

      • Acetylated lysines act as specific docking sites for bromodomain-containing proteins, which recruit chromatin remodeling complexes (e.g., SWI/SNF) to open chromatin for transcription.


Biochemical contrast between condensed heterochromatin and relaxed euchromatin mediated by histone tail acetylation and methylation
  • Histone Methylation Dynamics:

    • Chemical Reaction: Enzymatic transfer of one, two, or three methyl groups (−CH3-\text{CH}_3) to lysine or arginine residues on histone tails, utilizing S-adenosylmethionine (SAM)S\text{-adenosylmethionine (SAM)} as the universal methyl donor.

    • Enzymatic Regulators:

      • Histone Methyltransferases (HMTs): Catalyze site-specific mono-, di-, or trimethylation.

      • Histone Demethylases (HDMs): Catalyze the oxidative removal of methyl groups.

    • Functional Outcomes (The Histone Code): Unlike acetylation, methylation does not alter electrical charges; its functional consequence depends entirely upon the specific amino acid residue modified and the valency of methylation:

      • H3K4me\mathbf{H3K4me} (Histone H3 Lysine 4 methylation): Concentrated around promoter regions; correlates with transcriptional activation and open euchromatin.

      • H3K9me\mathbf{H3K9me} (Histone H3 Lysine 9 methylation): Spreads across gene bodies and repeated sequences; recruits Heterochromatin Protein 1 (HP1) to form transcriptionally repressed constitutive heterochromatin.

      • H3K27me\mathbf{H3K27me} (Histone H3 Lysine 27 methylation): Catalyzed by Polycomb Repressive Complex 2 (PRC2); establishes transcriptionally repressed facultative heterochromatin.


Histone methylation marks indicating active transcription (H3K4me), constitutive heterochromatin (H3K9me), and facultative heterochromatin (H3K27me)
  • Comparison of Epigenetic Writers and Modifiers:

    • Chemical Group Added: Methylases transfer a methyl group (−CH3-\text{CH}_3); Acetylases transfer an acetyl group (−COCH3-\text{COCH}_3).

    • Primary Molecular Targets: Methylases target the carbon-5 position of cytosine in DNA and lysine/arginine residues on histone tails; Acetylases target lysine residues on histone amino-terminal tails.

    • Typical Impact on Transcription: DNA and specific histone methylations predominantly silence transcription; histone acetylation promotes and activates transcription.

Environmental, Nutritional, and Pathological Epigenetics

  • Nutrient Signalling and Epigenetic Modulation:

    • Extracellular nutrients (carbohydrates, lipids, amino acids) act through membrane receptors (such as Receptor Tyrosine Kinases, RTKs) or nuclear receptors to initiate intracellular kinase cascades.

    • These cascades activate downstream transcription factor networks (including \text{NF-\kappa B}, STAT3\text{STAT3}, AP1\text{AP1}, PPAR\text{PPAR}, SREBP\text{SREBP}, ChREBP\text{ChREBP}, and p53\text{p53}) and modulate non-coding RNAs (ncRNAs\text{ncRNAs}), altering chromatin structure and transcriptional output.


Integration of dietary compounds, receptor-mediated signaling pathways, and nuclear epigenetic modifications
  • One-Carbon Metabolism and the Methionine Cycle:

    • S-Adenosylmethionine (SAM)S\text{-Adenosylmethionine (SAM)} is the obligatory methyl group donor for both DNMTs and HMTs.

    • SAM biosynthesis occurs within the hepatic methionine cycle, supported by dietary methyl-donor nutrients: methionine, folate (vitamin B9\text{B}_9), choline, betaine, and enzymatic cofactors (vitamins B2\text{B}_2, B6\text{B}_6, and B12\text{B}_{12}).

    • Folate enters One-Carbon (C1) metabolism to generate N-5-methyltetrahydrofolate (5-MTHF)N\text{-5-methyltetrahydrofolate (5-MTHF)}, which donates its methyl group to homocysteine via cobalamin-dependent methionine synthase, generating methionine, the direct precursor of SAM.

    • Clinical Consequence of Folate Deficiency: Maternal folate deprivation during embryonic development depletes the SAM pool, leading to widespread genomic hypomethylation. This disrupts closing of the neural tube, causing congenital neural tube defects such as anencephaly and spina bifida.

  • Nutritional Epigenetics in Caste Differentiation (Apis mellifera):

    • Female honeybee larvae have identical diploid genomes (2n2n) but differentiate into either sterile worker bees or fertile queen bees based entirely on larval nutrition.

    • Larvae fed worker jelly develop into workers, exhibiting DNA methylation that represses queen-development genes.

    • Selected larvae fed continuously with royal jelly develop into queens. Royal jelly contains bioactive components that inhibit DNA methyltransferases, leading to genome-wide DNA demethylation and activating the phenotypic program of the queen.


Morphological divergence of Apis mellifera castes into worker, queen, and drone
  • Phenotypic Comparison Between Honeybee Castes (Apis mellifera):

    • Mass at emergence: Worker 81 to 151 mg81\text{ to }151\,\text{mg}; Queen 178 to 292 mg178\text{ to }292\,\text{mg}.

    • Development period (egg to adult): Worker 16 to 24 days16\text{ to }24\,\text{days}; Queen 14 to 17 days14\text{ to }17\,\text{days}.

    • Lifespan: Worker 15 to 38 days15\text{ to }38\,\text{days} (summer) or 140 days140\,\text{days} (winter); Queen 1 to 3 years1\text{ to }3\,\text{years} (up to 8 years8\,\text{years} in documented cases).

    • Facets in compound eye: Worker 5,000 to 6,0005{,}000\text{ to }6{,}000; Queen 3,5003{,}500.

    • Placoid olfactory sensillae: Worker 2,7002{,}700; Queen 1,6001{,}600.

    • Pollen basket (corbicula): Worker present (Yes); Queen absent (No).

    • Wax glands: Worker present (Yes); Queen absent (No).

    • Spermatheca: Worker rudimentary; Queen fully developed and large.

    • Ovarioles: Worker 2 to 122\text{ to }12; Queen 150 to 180150\text{ to }180.

    • Sting barbs: Worker present (Yes); Queen rudimentary.

    • Mandibular glands: Worker large; Queen very large.

    • Nasonov glands: Worker present (Yes); Queen absent (No).

    • Dance communication: Worker functional (Yes); Queen absent (No).

  • Epigenetic Alterations in Malignancy:

    • Promoter Hypermethylation: In cancer cells, CpG islands in the promoters of Tumor Suppressor Genes (TSGs) undergo aberrant hypermethylation. This recruits MBDs, DNMTs, and HDACs, condensing chromatin and silencing genes that control cell cycle arrest, DNA mismatch repair, and apoptosis (e.g., RB1\textit{RB1}, MLH1\textit{MLH1}, BRCA1\textit{BRCA1}, CDKN2A/p16INK4a\textit{CDKN2A/p16}^{INK4a}.

    • Global Hypomethylation: Concurrently, global hypomethylation of repetitive intergenic elements, retrotransposons, and oncogene promoters generates chromosomal instability and aberrant proto-oncogene activation.

    • Histone Code Disruption: Somatic mutations in or overexpression of epigenetic regulators (such as the gain-of-function mutation of the H3K27 methyltransferase EZH2 or loss of function in histone demethylases) repress differentiation pathways and sustain malignant proliferation.


Mechanism of tumor suppressor gene silencing in cancer cells via CpG hypermethylation and histone deacetylation

Experimental Analysis of Cell Signalling: Immunoblotting

  • Immunoblotting (Western Blotting) Workflow:

    1. Sample Preparation & Extraction: Total cellular protein is extracted from cells, biological fluids, or tissue homogenates using lysis buffers containing protease and phosphatase inhibitors.

    2. Electrophoretic Separation: Denatured proteins are separated by molecular mass via Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE).

    3. Electroblotting Transfer: The resolved protein bands within the gel matrix are electrophoretically transferred onto a solid support membrane (nitrocellulose or polyvinylidene difluoride, PVDF).

    4. Immunodetection: The membrane is blocked with a non-specific protein solution (e.g., 5%5\% bovine serum albumin or non-fat milk), incubated with a sequence-specific primary antibody targeting the protein of interest, and probed with an enzyme-conjugated (e.g., Horseradish Peroxidase, HRP) or fluorophore-conjugated secondary antibody.

    5. Chemiluminescent Imaging & Densitometry: Luminescence or fluorescence is captured digitally, and band volume/optical density is quantified relative to loading controls.


Standard methodological pipeline of SDS-PAGE, electroblotting, and antibody-based visualization
  • Monitoring Signal Transduction via the Insulin/Akt Pathway:

    • Insulin binds to its cell-surface Receptor Tyrosine Kinase (RTK), inducing autophosphorylation and recruitment of Phosphoinositide 3-Kinase (PI3K).

    • PI3K catalyzes the phosphorylation of PIP2\text{PIP}_2 to yield phosphatidylinositol-3,4,5-trisphosphate (PIP3\text{PIP}_3).

    • PIP3\text{PIP}_3 recruits Phosphoinositide-Dependent Kinase 1 (PDK1) and Protein Kinase B (Akt) to the inner plasma membrane leaflet.

    • Full catalytic activation of Akt requires a dual phosphorylation mechanism:

      • Phosphorylation at Threonine 308 (Thr308\text{Thr}^{308}) located within the activation loop by PDK1.

      • Phosphorylation at Serine 473 (Ser473\text{Ser}^{473}) located within the hydrophobic carboxy-terminal domain by mechanistic target of rapamycin complex 2 (mTORC2).

    • Downstream Effector Pathways Controlled by Phospho-Akt:

      • Phosphorylates and inhibits the Rab-GAP AS160, promoting the mobilization and translocation of intracellular GLUT4 storage vesicles to the plasma membrane to stimulate glucose uptake and glycolysis.

      • Phosphorylates and inhibits Glycogen Synthase Kinase 3 (GSK3), relieving tonic inhibition on Glycogen Synthase (GS) to drive glycogen synthesis.

      • Phosphorylates FOXO transcription factors, excluding them from the nucleus to inhibit apoptosis and promote cell survival.

      • Phosphorylates and inhibits TSC1/2, releasing GTPase Rheb to activate mTORC1, which subsequently phosphorylates p70S6K and ribosomal protein S6 to drive protein translation, while repressing autophagy.

      • Activates ATP Citrate Lyase to supply cytosolic acetyl-CoA for fatty acid synthesis.

    • Western Blot Detection: Probing cell lysates with an anti-Phospho-Ser473 Akt\text{Phospho-Ser}^{473}\text{ Akt} antibody reveals band induction (55 to 72 kDa55\text{ to }72\,\text{kDa}) following insulin stimulation (+Insulin+\text{Insulin}), while total non-phosphorylated Akt levels remain invariant, serving as an internal loading reference.


Signal transduction cascade of the insulin-receptor-tyrosine-kinase-mediated PI3K/Akt pathway

Ribozymes and Catalytic RNA

  • The Discovery of Ribozymes:

    • RNA molecules can fold into complex tertiary structures mediated by non-Watson-Crick base-pairing, stem-loops, pseudoknots, and coordinated divalent metal cations (Mg2+\text{Mg}^{2+}).

    • Certain RNA sequences possess catalytic properties, functioning as RNA enzymes or ribozymes capable of catalyzing phosphodiester cleavage and ligation reactions without protein cofactors.

    • This discovery was made by Thomas Cech and Sidney Altman, who were jointly awarded the 1989 Nobel Prize in Chemistry.

  • Self-Splicing Mechanism of Group I Introns (Tetrahymena rRNA Precursor):

    • Group I self-splicing introns require an external guanosine nucleotide cofactor (guanosine, GMP, GDP, or GTP) containing a free 3′-OH3'\text{-OH} group.

    • First Transesterification Reaction: The 3′-OH3'\text{-OH} of the guanosine cofactor launches a nucleophilic attack on the phosphodiester bond at the 5′5' splice junction (upstream exon-intron interface). This cleaves the upstream exon and attaches the guanosine to the 5′5' terminus of the intron.

    • Second Transesterification Reaction: The newly generated, free 3′-OH3'\text{-OH} of the upstream exon launches a nucleophilic attack on the phosphodiester bond at the 3′3' splice junction (intron-downstream exon interface). This ligates the upstream and downstream exons into mature rRNA and releases the intact 414-nucleotide (nt)414\text{-nucleotide (nt)} linear group I intron.

    • Autocatalytic Processing of the Excised Intron: The liberated 414-nt414\text{-nt} linear intron undergoes successive intramolecular cyclization and autolytic cleavage events, releasing a 15-nt15\text{-nt} fragment to yield a 399-nt399\text{-nt} circular intermediate, followed by an additional 4-nt4\text{-nt} loss (19 nucleotides19\text{ nucleotides} total released). This yields the shortened linear catalytic ribozyme designated L-19 RNAL\text{-}19\,\text{RNA} (395 nucleotides395\text{ nucleotides}), which possesses sequence-specific RNA endonuclease and transferase catalytic capabilities.


Autocatalytic self-splicing and maturation of the Tetrahymena group I intron producing L-19 RNA

Mechanisms and Applications of RNA Interference (RNAi)

  • Discovery of RNA Interference:

    • Discovered by Andrew Fire and Craig Mello through experiments in the nematode Caenorhabditis elegans, for which they received the 2006 Nobel Prize in Physiology or Medicine.

    • Microinjecting single-stranded sense RNA complementary to the unc-22 muscle protein gene yielded no phenotype.

    • Microinjecting single-stranded antisense RNA alone produced no physiological defect.

    • Microinjecting double-stranded RNA (dsRNA) homologous to the unc-22 sequence provoked potent, coordinated muscular twitching and paralysis, matching the structural and behavioral phenotype of a genetic null mutation.


Phenotypic outcome of microinjecting sense, antisense, and double-stranded RNA into Caenorhabditis elegans
  • Cellular Roles of RNA Interference Pathways:

    • Antiviral Defense: Recognizes and destroys foreign, replicating double-stranded RNA viral genomes or replicative intermediates, blocking viral proliferation.

    • Endogenous Gene Regulation via MicroRNAs: Endogenously encoded microRNAs (miRNAs) are transcribed from non-coding genes or introns to direct post-transcriptional gene silencing, matching physiological developmental requirements.

    • Targeted Gene Silencing: Transfecting synthetic double-stranded RNAs (siRNAs or shRNAs) enables sequence-specific gene knockdown for functional biological and pharmacological studies.


Major cellular processes utilizing RNA interference
  • Step-by-Step Biochemical Mechanism of RNAi:

    1. Substrate Processing by Dicer: Long cytoplasmic dsRNA molecules (derived from viral infection, transcription, or artificial delivery) are recognized and cleaved by the RNase III endonuclease Dicer into 21 to 23 base-pair21\text{ to }23\,\text{base-pair} duplexes termed small interfering RNAs (siRNAs), carrying characteristic two-nucleotide 3′3' overhangs and 5′5' phosphate groups.

    2. RISC Loading & Assembly: The siRNA duplex is loaded into a multi-protein ribonucleoprotein complex termed the RNA-Induced Silencing Complex (RISC).

    3. Strand Selection and Activation: The central catalytic endonuclease of RISC, Argonaute (Ago2), cleaves and ejects the passenger strand (sense strand). The guide strand (antisense strand) is retained within the complex to produce activated RISC (RISC∗\text{RISC}^*).

    4. Target Recognition & Cleavage: The single-stranded guide RNA directs RISC∗\text{RISC}^* to bind complementary target mRNA{\text{mRNA}} via base pairing. Argonaute cleaves the phosphodiester bond of the target mRNA between bases 10 and 11 relative to the 5′5' end of the guide strand.

    5. Target mRNA Degradation: Cleavage exposes the mRNA fragments to cellular exonucleases (XRN1 and the exosome complex), leading to total target transcript degradation and translational arrest.


Biochemical steps of Dicer-mediated dsRNA processing, RISC loading, guide strand activation, and mRNA cleavage
  • microRNAs (miRNAs) and Post-Transcriptional Gene Silencing:

    • Endogenous microRNAs (≈22 nt\approx 22\,\text{nt}) are derived from longer hairpin-containing primary transcripts (pri-miRNAs) processed sequentially by Drosha in the nucleus and Dicer in the cytoplasm.

    • Unlike the near-perfect Watson-Crick base-pairing of siRNAs, animal miRNAs typically bind with imperfect complementarity to the 3′-untranslated regions (3’-UTRs)3'\text{-untranslated regions (3'-UTRs)} of target mRNAs via a short "seed region" (nucleotides 2 through 8 at the 5′5' end).

    • This imperfect mismatch mediates repression primarily by blocking translational initiation/elongation or promoting deadenylation and mRNA decay.

    • miRNAs can also indirectly influence the epigenome by downregulating core chromatin-modifying enzymes, such as DNMT3A/3B and HDACs.

  • Experimental Gene Knockdown Example: mVps45mVps45 and Insulin Action:

    • RNA interference was utilized to evaluate the intracellular trafficking protein mVps45mVps45 in insulin-responsive adipocytes using specific short hairpin RNAs (shRNA#1\text{shRNA}\#1 and shRNA#2\text{shRNA}\#2).

    • Immunoblotting verified target silencing: mVps45mVps45 protein abundance (62 kDa62\,\text{kDa}) was knocked down by shRNA#1\text{shRNA}\#1 and shRNA#2\text{shRNA}\#2 relative to non-transfected controls and scrambled shRNA controls, while the internal control (32.5 kDa32.5\,\text{kDa}) remained constant.

    • Functional Analysis: Depletion of mVps45mVps45 by shRNA#1\text{shRNA}\#1 markedly suppressed insulin-stimulated 2-deoxyglucose (deGlc\text{deGlc}) uptake across all insulin concentrations (log⁡[Insulin] nM\log[\text{Insulin}]\,\text{nM} from −0.5-0.5 to 3.03.0), lowering maximum glucose transport from 100%100\% in control cells down to ≈35%\approx 35\%. This demonstrated that mVps45mVps45 is required for GLUT4 vesicle translocation to the plasma membrane.


Suppression of insulin-stimulated deoxyglucose uptake following shRNA-mediated knockdown of mVps45

Targeted Genome Editing: CRISPR/Cas9

  • Discovery and Impact:

    • Engineered from a bacterial adaptive immune system into a programmable RNA-guided genome-editing platform by Jennifer Doudna and Emmanuelle Charpentier, who received the 2020 Nobel Prize in Chemistry.

  • Mechanistic Components:

    • Cas9 Endonuclease: A multidomain metallonuclease derived from Streptococcus pyogenes harboring two distinct catalytic cleavage domains: the HNH domain (cleaves the target DNA strand complementary to the guide RNA) and the RuvC-like domain (cleaves the non-complementary strand).

    • Single Guide RNA (gRNA): An engineered chimeric RNA molecule composed of a synthetic 20-nucleotide20\text{-nucleotide} variable spacer domain (which matches the target genomic sequence) fused to a structured constant scaffold domain (which mediates high-affinity assembly with Cas9).

    • Protospacer Adjacent Motif (PAM): A short conserved consensus sequence (5′-NGG-3′5'\text{-NGG-}3' for S. pyogenes Cas9) located immediately adjacent to the 3′3' end of the genomic target sequence. Cas9 will only bind and unwind target DNA if an exact PAM match is present.

  • DNA Cleavage and Repair Pathways:

    • Once the Cas9:gRNA ribonucleoprotein complex binds the complementary target locus adjacent to a PAM, the HNH and RuvC nuclease domains generate a precise double-strand break (DSB) in the target DNA 3 base pairs3\,\text{base pairs} upstream of the PAM site.

    • Non-Homologous End Joining (NHEJ): The cell initiates an error-prone repair pathway in which free DNA ends are religated without a homologous repair template. This often introduces stochastic insertions, deletions (indels), or reading frameshifts that produce premature stop codons, knocking out gene function.

    • Homology-Directed Repair (HDR): In the presence of an exogenous donor DNA repair template harboring homology arms, the cell can repair the double-strand break via homologous recombination, enabling precise nucleotide substitutions, targeted corrections, or exogenous sequence knock-ins.


Molecular mechanism of CRISPR/Cas9-mediated site-specific cleavage and non-homologous end joining repair